Pharma Journalist - Page 43 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Novartis to Build Major U.S. Manufacturing Hub in North Carolina

FDA Approves Expanded Dosing Options for Regeneron’s EYLEA HD in Retinal Diseases

Moderna Expands U.S. Manufacturing with New Onshore Drug Product Facility

Merck’s Two-Drug HIV Regimen Meets Phase 3 Trial Goals

EC Approves First Simponi Biosimilar Gobivaz in Europe

FDA Approves Arrowhead’s REDEMPLO, the First siRNA Therapy for Familial Chylomicronemia Syndrome

EU Approves First Subcutaneous Version of Keytruda for All Adult Indications

LNP Innovation Surges as 5th LNP Summit Unveils 2026 Agenda

EU Approves First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis

FDA Approves AbbVie’s EPKINLY Combination for Relapsed or Refractory Follicular Lymphoma